We are live on ! Find out more
GT

Glenview Trust Portfolio holdings

AUM $7.23B
1-Year Est. Return 27.68%
This Fund
S&P 500
This Quarter Est. Return
+16.49%
1 Year Est. Return
+27.68%
3 Year Est. Return
+99.19%
5 Year Est. Return
+131.61%
10 Year Est. Return
AUM
$7.23B
AUM Growth
+$864M
Cap. Flow
+$101M
Cap. Flow %
1.39%
Top 10 Hldgs %
34.7%
Holding
533
New
33
Increased
204
Reduced
204
Closed
16

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$14.3M
2
VOT icon
Vanguard Morningstar Mid-Cap Growth ETF
VOT
+$7.86M
3
SPGI icon
S&P Global
SPGI
+$5.78M
4
NVDA icon
NVIDIA
NVDA
+$3.43M
5
HUM icon
Humana
HUM
+$2.77M

Sector Composition

Rank Sector Weight
1 Miscellaneous 29.79%
2 Technology 25.38%
3 Financials 9.57%
4 Healthcare 8.76%
5 Industrials 7.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
26
Berkshire Hathaway Class B
BRK.B
$1.09T
$67.8M 0.94%
135,504
+7,716
+6% +$3.71M
CSCO icon
27
Cisco
CSCO
$428B
$57.6M 0.8%
490,580
+20,182
+4% +$2.11M
AMD icon
28
Advanced Micro Devices
AMD
$745B
$56.6M 0.78%
97,457
+7,285
+8% +$2.99M
BA icon
29
Boeing
BA
$166B
$55.8M 0.77%
257,809
+14,406
+6% +$3.21M
VNQ icon
30
Vanguard Real Estate ETF
VNQ
$38.4B
$54.5M 0.75%
564,978
+20,415
+4% +$1.95M
PG icon
31
Procter & Gamble
PG
$341B
$53.1M 0.73%
362,346
-98,131
-21% -$14.3M
LOW icon
32
Lowe's Companies
LOW
$113B
$50.8M 0.7%
230,389
+10,735
+5% +$2.44M
ISRG icon
33
Intuitive Surgical
ISRG
$131B
$50.5M 0.7%
126,929
+3,695
+3% +$1.61M
MRK icon
34
Merck
MRK
$376B
$49M 0.68%
381,609
+4,717
+1% +$552K
AVUS icon
35
Avantis US Equity ETF
AVUS
$14.6B
$46.3M 0.64%
361,185
+10,859
+3% +$1.34M
CSMD icon
36
Congress SMid Growth ETF
CSMD
$470M
$45.8M 0.63%
1,253,954
+41,789
+3% +$1.4M
ORCL icon
37
Oracle
ORCL
$444B
$44.8M 0.62%
305,415
+12,044
+4% +$2.18M
LRCX icon
38
Lam Research
LRCX
$366B
$43.4M 0.6%
100,253
+1,993
+2% +$605K
IBM icon
39
IBM
IBM
$221B
$43.4M 0.6%
154,329
-1,888
-1% -$476K
AVUV icon
40
Avantis US Small Cap Value ETF
AVUV
$31.6B
$42.2M 0.58%
337,905
+5,082
+2% +$606K
GOOG icon
41
Alphabet (Google) Class C
GOOG
$4.15T
$42M 0.58%
118,926
-285
-0.2% -$102K
HON icon
42
Honeywell
HON
$65.8B
$41.8M 0.58%
180,033
+3,169
+2% +$707K
CVX icon
43
Chevron
CVX
$415B
$41.3M 0.57%
249,324
+2,755
+1% +$513K
XOM icon
44
ExxonMobil
XOM
$667B
$39.9M 0.55%
291,839
+1,146
+0.4% +$172K
JNJ icon
45
Johnson & Johnson
JNJ
$671B
$38.3M 0.53%
150,964
-1,591
-1% -$371K
AMAT icon
46
Applied Materials
AMAT
$346B
$38.3M 0.53%
52,980
+7,449
+16% +$3.44M
ECL icon
47
Ecolab
ECL
$78.2B
$37.6M 0.52%
134,858
+8,585
+7% +$2.26M
KO icon
48
Coca-Cola
KO
$382B
$37.3M 0.52%
458,963
+537
+0.1% +$42.4K
C icon
49
Citigroup
C
$232B
$36.8M 0.51%
262,946
+3,844
+1% +$500K
UNP icon
50
Union Pacific
UNP
$172B
$36.6M 0.51%
134,738
-1,530
-1% -$402K

Similar funds

Glenview Trust's Q2 2026 Portfolio in Review

As of Q2 2026, Glenview Trust held 533 positions worth $7.23B, up 14% from $6.37B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Glenview Trust's Q2 2026 filing shows 33 new, 204 increased, 204 reduced and 16 closed positions. Its largest new stake was Avantis US Mid Cap Value ETF: 49,076 shares worth $3.95M. The largest sale was Procter & Gamble, an estimated $14.3M.

By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 30% a quarter earlier, followed by Technology and Financials.

  • Glenview Trust's largest Q2 2026 buy was Avantis US Mid Cap Value ETF: 49,076 shares worth $3.95M.
  • Glenview Trust added most to Emerson Electric in Q2 2026, an estimated $14.6M increase.
  • Glenview Trust's biggest Q2 2026 reduction was Procter & Gamble, cutting an estimated $14.3M.
  • Glenview Trust fully exited iShares Core Universal USD Bond ETF in Q2 2026, selling an estimated $601K.
  • Glenview Trust's ten largest holdings make up 35% of its $7.23B portfolio in Q2 2026.
  • Glenview Trust opened 33 new positions and closed 16 in Q2 2026.
  • Glenview Trust's portfolio value rose 14% quarter-over-quarter to $7.23B.

Based on Glenview Trust's 13F filing for Q2 2026, filed 11 Aug 2026.